These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
(Mark One)
|
|
|
|
|
|
þ
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
|
|
Large Accelerated Filer
þ
|
|
Accelerated Filer
o
|
|
Non-Accelerated Filer
o
|
|
Smaller Reporting Company
o
|
|
(Do not check if a smaller reporting company.)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions except per share data - unaudited)
|
2016
|
|
|
2015
|
|
||
Sales
|
$
|
1,193
|
|
|
$
|
1,163
|
|
Cost of sales
|
807
|
|
|
771
|
|
||
Gross profit
|
386
|
|
|
392
|
|
||
|
|
|
|
||||
Selling, general and administrative expense
|
239
|
|
|
224
|
|
||
Research and development expense
|
23
|
|
|
25
|
|
||
Equity and other income
|
13
|
|
|
8
|
|
||
Operating income
|
137
|
|
|
151
|
|
||
|
|
|
|
||||
Net interest and other financing expense
|
132
|
|
|
42
|
|
||
Net gain (loss) on divestitures
|
(1
|
)
|
|
2
|
|
||
Income from continuing operations before income taxes
|
4
|
|
|
111
|
|
||
Income tax expense (benefit) - Note I
|
(6
|
)
|
|
20
|
|
||
Income from continuing operations
|
10
|
|
|
91
|
|
||
Loss from discontinued operations (net of tax) - Note D
|
—
|
|
|
(2
|
)
|
||
Net income
|
10
|
|
|
89
|
|
||
Net income attributable to noncontrolling interest
|
11
|
|
|
—
|
|
||
Net income (loss) attributable to Ashland
|
$
|
(1
|
)
|
|
$
|
89
|
|
|
|
|
|
||||
PER SHARE DATA
|
|
|
|
||||
Basic earnings per share - Note L
|
|
|
|
|
|
||
Income (loss) from continuing operations attributable to Ashland
|
$
|
(0.01
|
)
|
|
$
|
1.39
|
|
Loss from discontinued operations
|
—
|
|
|
(0.02
|
)
|
||
Net income (loss) attributable to Ashland
|
$
|
(0.01
|
)
|
|
$
|
1.37
|
|
|
|
|
|
||||
Diluted earnings per share - Note L
|
|
|
|
|
|
||
Income (loss) from continuing operations attributable to Ashland
|
$
|
(0.01
|
)
|
|
$
|
1.38
|
|
Loss from discontinued operations
|
—
|
|
|
(0.03
|
)
|
||
Net income (loss) attributable to Ashland
|
$
|
(0.01
|
)
|
|
$
|
1.35
|
|
|
|
|
|
||||
DIVIDENDS PAID PER COMMON SHARE
|
$
|
0.39
|
|
|
$
|
0.39
|
|
|
|
|
|
||||
COMPREHENSIVE INCOME (LOSS)
|
|
|
|
||||
Net income
|
$
|
10
|
|
|
$
|
89
|
|
Other comprehensive income (loss), net of tax - Note M
|
|
|
|
||||
Unrealized translation loss
|
(146
|
)
|
|
(61
|
)
|
||
Pension and postretirement obligation adjustment
|
(1
|
)
|
|
(3
|
)
|
||
Unrealized gain on available-for-sale securities
|
—
|
|
|
6
|
|
||
Other comprehensive loss
|
(147
|
)
|
|
(58
|
)
|
||
Comprehensive income (loss)
|
(137
|
)
|
|
31
|
|
||
Comprehensive income attributable to noncontrolling interest
|
10
|
|
|
—
|
|
||
Comprehensive income (loss) attributable to Ashland
|
$
|
(147
|
)
|
|
$
|
31
|
|
|
|
|
|
|
|
|
|
|
|
December 31
|
|
|
September 30
|
|
||
(In millions - unaudited)
|
2016
|
|
|
2016
|
|
||
|
|
|
|
||||
ASSETS
|
|
|
|
||||
Current assets
|
|
|
|
||||
Cash and cash equivalents
|
$
|
704
|
|
|
$
|
1,188
|
|
Accounts receivable
(a)
|
858
|
|
|
894
|
|
||
Inventories - Note F
|
666
|
|
|
671
|
|
||
Other assets
|
106
|
|
|
113
|
|
||
Total current assets
|
2,334
|
|
|
2,866
|
|
||
Noncurrent assets
|
|
|
|
|
|
||
Property, plant and equipment
|
|
|
|
||||
Cost
|
4,283
|
|
|
4,343
|
|
||
Accumulated depreciation
|
2,097
|
|
|
2,119
|
|
||
Net property, plant and equipment
|
2,186
|
|
|
2,224
|
|
||
Goodwill - Note G
|
2,348
|
|
|
2,401
|
|
||
Intangibles - Note G
|
1,026
|
|
|
1,064
|
|
||
Restricted investments - Note E
|
297
|
|
|
292
|
|
||
Asbestos insurance receivable - Note K
|
194
|
|
|
196
|
|
||
Equity and other unconsolidated investments
|
60
|
|
|
57
|
|
||
Deferred income taxes
|
199
|
|
|
177
|
|
||
Other assets
|
419
|
|
|
420
|
|
||
Total noncurrent assets
|
6,729
|
|
|
6,831
|
|
||
Total assets
|
$
|
9,063
|
|
|
$
|
9,697
|
|
|
|
|
|
||||
LIABILITIES AND EQUITY
|
|
|
|
|
|
||
Current liabilities
|
|
|
|
|
|
||
Short-term debt - Note H
|
$
|
92
|
|
|
$
|
170
|
|
Current portion of long-term debt - Note H
|
15
|
|
|
19
|
|
||
Trade and other payables
|
458
|
|
|
541
|
|
||
Accrued expenses and other liabilities
|
451
|
|
|
486
|
|
||
Total current liabilities
|
1,016
|
|
|
1,216
|
|
||
Noncurrent liabilities
|
|
|
|
|
|
||
Long-term debt - Note H
|
2,825
|
|
|
3,055
|
|
||
Employee benefit obligations - Note J
|
1,040
|
|
|
1,080
|
|
||
Asbestos litigation reserve - Note K
|
674
|
|
|
686
|
|
||
Deferred income taxes
|
69
|
|
|
69
|
|
||
Other liabilities
|
438
|
|
|
426
|
|
||
Total noncurrent liabilities
|
5,046
|
|
|
5,316
|
|
||
Commitments and contingencies - Note K
|
|
|
|
|
|
||
Equity
|
|
|
|
||||
Total Ashland stockholders' equity
|
3,175
|
|
|
3,347
|
|
||
Noncontrolling interest
|
(174
|
)
|
|
(182
|
)
|
||
Total equity
|
3,001
|
|
|
3,165
|
|
||
Total liabilities and equity
|
$
|
9,063
|
|
|
$
|
9,697
|
|
|
|
|
|
(a)
|
Accounts receivable includes an allowance for doubtful accounts of
$14 million
at
December 31, 2016
and
September 30, 2016
.
|
|
|
|
|
|
|
|
|
|
(In millions - unaudited)
|
Common
stock
|
|
|
Paid-in
capital
|
|
|
Retained
earnings
|
|
|
Accumulated
other
comprehensive
income (loss)
|
|
(a)
|
Noncontrolling interest
|
|
(b)
|
Total
|
|
||||||
BALANCE AT SEPTEMBER 30, 2016
|
$
|
1
|
|
|
$
|
923
|
|
|
$
|
2,704
|
|
|
$
|
(281
|
)
|
|
$
|
(182
|
)
|
|
$
|
3,165
|
|
Total comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net income (loss)
|
|
|
|
|
|
(1
|
)
|
|
|
|
11
|
|
|
10
|
|
||||||||
Other comprehensive loss
|
|
|
|
|
|
|
(146
|
)
|
|
(1
|
)
|
|
(147
|
)
|
|||||||||
Regular dividends, $0.39 per common share
|
|
|
|
|
|
|
(24
|
)
|
|
|
|
|
|
|
(24
|
)
|
|||||||
Common shares issued under stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
incentive and other plans
(c)
|
|
|
|
(1
|
)
|
|
|
|
|
|
|
|
|
(1
|
)
|
||||||||
Distributions to noncontrolling interest
|
|
|
|
|
|
|
|
|
(2
|
)
|
|
(2
|
)
|
||||||||||
BALANCE AT DECEMBER 31, 2016
|
$
|
1
|
|
|
$
|
922
|
|
|
$
|
2,679
|
|
|
$
|
(427
|
)
|
|
$
|
(174
|
)
|
|
$
|
3,001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
At
December 31, 2016
and
September 30, 2016
, the after-tax accumulated other comprehensive loss attributable to Ashland of
$427 million
and
$281 million
, respectively, was comprised of unrecognized prior service credits as a result of certain employee benefit plan amendments of
$45 million
and
$46 million
, respectively, net unrealized translation losses of
$478 million
and
$333 million
, respectively, and net unrealized gain on available-for-sale securities of
$6 million
. At
December 31, 2016
and
September 30, 2016
, amounts attributable to noncontrolling interest included unrecognized prior service credits of
$9 million
and net unrealized translation losses of
$3 million
and
$2 million
, respectively.
|
(b)
|
See Note B for discussion of Valvoline Inc. noncontrolling interest.
|
(c)
|
Common shares issued were
56,590
for the
three
months ended
December 31, 2016
.
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions - unaudited)
|
2016
|
|
|
2015
|
|
||
CASH FLOWS PROVIDED (USED) BY OPERATING ACTIVITIES FROM
|
|
|
|
||||
CONTINUING OPERATIONS
|
|
|
|
||||
Net income
|
$
|
10
|
|
|
$
|
89
|
|
Loss from discontinued operations (net of tax)
|
—
|
|
|
2
|
|
||
Adjustments to reconcile income from continuing operations to
|
|
|
|
|
|
||
cash flows from operating activities
|
|
|
|
|
|
||
Depreciation and amortization
|
77
|
|
|
83
|
|
||
Original issue discount and debt issuance cost amortization
|
95
|
|
|
3
|
|
||
Deferred income taxes
|
2
|
|
|
3
|
|
||
Equity income from affiliates
|
(4
|
)
|
|
(4
|
)
|
||
Distributions from equity affiliates
|
—
|
|
|
5
|
|
||
Stock based compensation expense
|
6
|
|
|
8
|
|
||
Gain on early retirement of debt
|
(3
|
)
|
|
—
|
|
||
Gain on available-for-sale securities
|
(3
|
)
|
|
(2
|
)
|
||
Net loss (gain) on divestitures
|
1
|
|
|
(2
|
)
|
||
Pension contributions
|
(3
|
)
|
|
(4
|
)
|
||
Gain on post-employment plan remeasurement
|
(10
|
)
|
|
—
|
|
||
Change in operating assets and liabilities
(a)
|
(156
|
)
|
|
(115
|
)
|
||
Total cash flows provided by operating activities from continuing operations
|
12
|
|
|
66
|
|
||
CASH FLOWS PROVIDED (USED) BY INVESTING ACTIVITIES FROM
|
|
|
|
|
|
||
CONTINUING OPERATIONS
|
|
|
|
|
|
||
Additions to property, plant and equipment
|
(43
|
)
|
|
(53
|
)
|
||
Proceeds from disposal of property, plant and equipment
|
—
|
|
|
1
|
|
||
Purchase of operations - net of cash acquired
|
—
|
|
|
(4
|
)
|
||
Uses from sale of operations or equity investments
|
—
|
|
|
(2
|
)
|
||
Net purchase of funds restricted for specific transactions
|
(2
|
)
|
|
—
|
|
||
Reimbursements from restricted investments
|
—
|
|
|
7
|
|
||
Proceeds from the settlement of derivative instruments
|
4
|
|
|
7
|
|
||
Total cash flows used by investing activities from continuing operations
|
(41
|
)
|
|
(44
|
)
|
||
CASH FLOWS PROVIDED (USED) BY FINANCING ACTIVITIES FROM
|
|
|
|
|
|
||
CONTINUING OPERATIONS
|
|
|
|
|
|
||
Repayment of long-term debt
|
(318
|
)
|
|
(14
|
)
|
||
Premium on long-term debt repayment
|
(5
|
)
|
|
—
|
|
||
Proceeds (repayment) from short-term debt
|
(78
|
)
|
|
319
|
|
||
Repurchase of common stock
|
—
|
|
|
(500
|
)
|
||
Debt issuance costs
|
(4
|
)
|
|
—
|
|
||
Cash dividends paid
|
(24
|
)
|
|
(24
|
)
|
||
Distributions to noncontrolling interest
|
(2
|
)
|
|
—
|
|
||
Excess tax benefits related to share-based payments
|
(4
|
)
|
|
—
|
|
||
Total cash flows used by financing activities from continuing operations
|
(435
|
)
|
|
(219
|
)
|
||
CASH USED BY CONTINUING OPERATIONS
|
(464
|
)
|
|
(197
|
)
|
||
Cash used by discontinued operations
|
|
|
|
|
|
||
Operating cash flows
|
(12
|
)
|
|
(10
|
)
|
||
Investing cash flows
|
—
|
|
|
—
|
|
||
Total cash used by discontinued operations
|
(12
|
)
|
|
(10
|
)
|
||
Effect of currency exchange rate changes on cash and cash equivalents
|
(8
|
)
|
|
(11
|
)
|
||
DECREASE IN CASH AND CASH EQUIVALENTS
|
(484
|
)
|
|
(218
|
)
|
||
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
|
1,188
|
|
|
1,257
|
|
||
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
$
|
704
|
|
|
$
|
1,039
|
|
|
|
|
|
(a)
|
Excludes changes resulting from operations acquired or sold.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Loss on disposal of discontinued operations (net of tax)
|
|
|
|
|
|
||
Water Technologies
|
$
|
—
|
|
|
$
|
(2
|
)
|
Total loss from discontinued operations (net of tax)
|
$
|
—
|
|
|
$
|
(2
|
)
|
|
|
|
|
|
|
|
|
|
(In millions)
|
Carrying
value
|
|
|
Total
fair
value
|
|
|
Quoted prices
in active
markets for
identical
assets
Level 1
|
|
|
Significant
other
observable
inputs
Level 2
|
|
|
Significant
unobservable
inputs
Level 3
|
|
|||||
Assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
$
|
704
|
|
|
$
|
704
|
|
|
$
|
704
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Restricted investments
(a)
|
327
|
|
|
327
|
|
|
327
|
|
|
—
|
|
|
—
|
|
|||||
Deferred compensation investments
(b)
|
184
|
|
|
184
|
|
|
34
|
|
|
150
|
|
|
—
|
|
|||||
Investments of captive insurance company
(b)
|
2
|
|
|
2
|
|
|
2
|
|
|
—
|
|
|
—
|
|
|||||
Foreign currency derivatives
|
17
|
|
|
17
|
|
|
—
|
|
|
17
|
|
|
—
|
|
|||||
Total assets at fair value
|
$
|
1,234
|
|
|
$
|
1,234
|
|
|
$
|
1,067
|
|
|
$
|
167
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Foreign currency derivatives
|
$
|
12
|
|
|
$
|
12
|
|
|
$
|
—
|
|
|
$
|
12
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Included in restricted investments and
$30 million
within other current assets in the Condensed Consolidated Balance Sheets.
|
(b)
|
Included in other noncurrent assets in the Condensed Consolidated Balance Sheets.
|
(In millions)
|
Carrying
value
|
|
|
Total
fair
value
|
|
|
Quoted prices
in active
markets for
identical
assets
Level 1
|
|
|
Significant
other
observable
inputs
Level 2
|
|
|
Significant
unobservable
inputs
Level 3
|
|
|||||
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Cash and cash equivalents
|
$
|
1,188
|
|
|
$
|
1,188
|
|
|
$
|
1,188
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Restricted investments
(a)
|
322
|
|
|
322
|
|
|
322
|
|
|
—
|
|
|
—
|
|
|||||
Deferred compensation investments
(b)
|
185
|
|
|
185
|
|
|
35
|
|
|
150
|
|
|
—
|
|
|||||
Investments of captive insurance company
(b)
|
4
|
|
|
4
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|||||
Foreign currency derivatives
|
3
|
|
|
3
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|||||
Total assets at fair value
|
$
|
1,702
|
|
|
$
|
1,702
|
|
|
$
|
1,549
|
|
|
$
|
153
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Foreign currency derivatives
|
$
|
5
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Included in restricted investments and
$30 million
within other current assets in the Condensed Consolidated Balance Sheets.
|
(b)
|
Included in other noncurrent assets in the Condensed Consolidated Balance Sheets.
|
|
|
|
|
|
|
|
|
|
|
December 31
|
|
|
September 30
|
|
||
(In millions)
|
2016
|
|
|
2016
|
|
||
Original cost
|
$
|
335
|
|
|
$
|
335
|
|
Accumulated investment income, settlement funds,
|
|
|
|
||||
and disbursements, net
|
(24
|
)
|
|
(3
|
)
|
||
Adjusted cost
(a)
|
311
|
|
|
332
|
|
||
Investment income
(b)
|
3
|
|
|
8
|
|
||
Unrealized gain
|
13
|
|
|
11
|
|
||
Unrealized loss
|
(2
|
)
|
|
—
|
|
||
Settlement funds
|
2
|
|
|
4
|
|
||
Disbursements
|
—
|
|
|
(33
|
)
|
||
Fair value
|
$
|
327
|
|
|
$
|
322
|
|
|
|
|
|
(a)
|
The adjusted cost of the demand deposit includes accumulated investment income, disbursements and settlements recorded in previous periods.
|
(b)
|
Investment income for the demand deposit includes interest income as well as dividend income transferred from the equity and corporate bond mutual funds.
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross
|
|
|
Gross
|
|
|
|
||||||
(In millions)
|
Adjusted Cost
|
|
|
Unrealized Gain
|
|
|
Unrealized Loss
|
|
|
Fair Value
|
|
||||
As of December 31, 2016
|
|
|
|
|
|
|
|
||||||||
Demand Deposit
|
$
|
11
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
11
|
|
Equity Mutual Fund
|
185
|
|
|
13
|
|
|
—
|
|
|
198
|
|
||||
Corporate bond Mutual Fund
|
120
|
|
|
—
|
|
|
(2
|
)
|
|
118
|
|
||||
Fair value
|
$
|
316
|
|
|
$
|
13
|
|
|
$
|
(2
|
)
|
|
$
|
327
|
|
|
|
|
|
|
|
|
|
||||||||
As of September 30, 2016
|
|
|
|
|
|
|
|
||||||||
Demand Deposit
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6
|
|
Equity Mutual Fund
|
185
|
|
|
8
|
|
|
—
|
|
|
193
|
|
||||
Corporate bond Mutual Fund
|
120
|
|
|
3
|
|
|
—
|
|
|
123
|
|
||||
Fair value
|
$
|
311
|
|
|
$
|
11
|
|
|
$
|
—
|
|
|
$
|
322
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Investment income
|
$
|
3
|
|
|
$
|
2
|
|
Disbursements
|
—
|
|
|
(7
|
)
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Foreign currency derivative gain
|
$
|
2
|
|
|
$
|
3
|
|
|
December 31
|
|
|
September 30
|
|
||
(In millions)
|
2016
|
|
|
2016
|
|
||
Foreign currency derivative assets
|
$
|
15
|
|
|
$
|
3
|
|
Notional contract values
|
678
|
|
|
333
|
|
||
|
|
|
|
||||
Foreign currency derivative liabilities
|
$
|
12
|
|
|
$
|
4
|
|
Notional contract values
|
629
|
|
|
530
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31
|
|
|
September 30
|
|
||
(In millions)
|
Consolidated balance sheet caption
|
2016
|
|
|
2016
|
|
||
Net investment hedge assets
(a)
|
Accounts receivable
|
$
|
2
|
|
|
$
|
—
|
|
Net investment hedge liabilities
(a)
|
Accrued expenses and other liabilities
|
—
|
|
|
1
|
|
||
|
|
|
|
|
(a)
|
Fair value of $0 denotes a value less than $1 million.
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Change in unrealized gain in AOCI
(a)
|
$
|
2
|
|
|
$
|
—
|
|
Tax impact of change in unrealized gain in AOCI
(a)
|
(1
|
)
|
|
—
|
|
||
|
|
|
|
(a)
|
$0 denotes a value less than $1 million.
|
|
|
|
|
December 31
|
|
|
September 30
|
|
||
(In millions)
|
2016
|
|
|
2016
|
|
||
Finished products
|
$
|
512
|
|
|
$
|
516
|
|
Raw materials, supplies and work in process
|
182
|
|
|
184
|
|
||
LIFO reserves
|
(28
|
)
|
|
(29
|
)
|
||
|
$
|
666
|
|
|
$
|
671
|
|
|
Specialty
|
|
|
Performance
|
|
|
|
|
|
|
|||||
(In millions)
|
Ingredients
|
|
|
Materials
|
|
(a)
|
Valvoline
|
|
(b)
|
Total
|
|
||||
Balance as of September 30, 2016
|
$
|
1,991
|
|
|
$
|
147
|
|
|
$
|
263
|
|
|
$
|
2,401
|
|
Acquisitions
(c)
|
—
|
|
|
—
|
|
|
4
|
|
|
4
|
|
||||
Currency translation adjustment
|
(54
|
)
|
|
(3
|
)
|
|
—
|
|
|
(57
|
)
|
||||
Balance as of December 31, 2016
|
$
|
1,937
|
|
|
$
|
144
|
|
|
$
|
267
|
|
|
$
|
2,348
|
|
|
|
|
|
|
|
|
|
(a)
|
As of
December 31, 2016
, goodwill was completely attributable to the Composites reporting unit due to the full impairment of the goodwill for the Intermediates/Solvents reporting unit during the fourth quarter of 2016.
|
(b)
|
As of
December 31, 2016
, goodwill consisted of
$89 million
for the Core North America reporting unit,
$139 million
for the Quick Lubes reporting unit and
$39 million
for the International reporting unit.
|
(c)
|
Relates to Valvoline Instant Oil Change
SM
center acquisitions during the
three
months ended
December 31, 2016
.
|
|
|
|
|
|
|
|
|
|
|
December 31, 2016
|
||||||||||
|
Gross
|
|
|
|
|
Net
|
|
||||
|
carrying
|
|
|
Accumulated
|
|
|
carrying
|
|
|||
(In millions)
|
amount
|
|
|
amortization
|
|
|
amount
|
|
|||
Definite-lived intangible assets
|
|
|
|
|
|
||||||
Trademarks and trade names
|
$
|
42
|
|
|
$
|
(20
|
)
|
|
$
|
22
|
|
Intellectual property
|
659
|
|
|
(284
|
)
|
|
375
|
|
|||
Customer relationships
|
530
|
|
|
(202
|
)
|
|
328
|
|
|||
Total definite-lived intangible assets
|
1,231
|
|
|
(506
|
)
|
|
725
|
|
|||
|
|
|
|
|
|
||||||
Indefinite-lived intangible assets
|
|
|
|
|
|
||||||
Trademarks and trade names
|
301
|
|
|
—
|
|
|
301
|
|
|||
Total intangible assets
|
$
|
1,532
|
|
|
$
|
(506
|
)
|
|
$
|
1,026
|
|
|
September 30, 2016
|
||||||||||
|
Gross
|
|
|
|
|
Net
|
|
||||
|
carrying
|
|
|
Accumulated
|
|
|
carrying
|
|
|||
(In millions)
|
amount
|
|
|
amortization
|
|
|
amount
|
|
|||
Definite-lived intangible assets
|
|
|
|
|
|
||||||
Trademarks and trade names
|
$
|
42
|
|
|
$
|
(19
|
)
|
|
$
|
23
|
|
Intellectual property
|
667
|
|
|
(273
|
)
|
|
394
|
|
|||
Customer relationships
|
546
|
|
|
(200
|
)
|
|
346
|
|
|||
Total definite-lived intangible assets
|
1,255
|
|
|
(492
|
)
|
|
763
|
|
|||
|
|
|
|
|
|
||||||
Indefinite-lived intangible assets
|
|
|
|
|
|
||||||
Trademarks and trade names
|
301
|
|
|
—
|
|
|
301
|
|
|||
Total intangible assets
|
$
|
1,556
|
|
|
$
|
(492
|
)
|
|
$
|
1,064
|
|
|
|
|
|
|
|
|
|
|
|
December 31
|
|
|
September 30
|
|
||
(In millions)
|
2016
|
|
|
2016
|
|
||
4.750% notes, due 2022
|
$
|
1,085
|
|
|
$
|
1,121
|
|
3.875% notes, due 2018
|
671
|
|
|
700
|
|
||
6.875% notes, due 2043
|
376
|
|
|
376
|
|
||
5.500% notes, due 2024
(a)
|
375
|
|
|
375
|
|
||
Term Loan, due 2021
(a)
|
296
|
|
|
375
|
|
||
2017 accounts receivable securitization facility
(a)
|
75
|
|
|
—
|
|
||
6.50% junior subordinated notes, due 2029
|
50
|
|
|
140
|
|
||
Other international loans, interest at a weighted-
|
|
|
|
|
|
||
average rate of 4.9% at December 31, 2016 (4.8% to 5.0%)
|
17
|
|
|
20
|
|
||
Medium-term notes, due 2019, interest of 9.4% at December 31, 2016
|
5
|
|
|
5
|
|
||
Term Loan, due 2017
|
—
|
|
|
150
|
|
||
Other
(b)
|
(18
|
)
|
|
(18
|
)
|
||
Total debt
|
2,932
|
|
|
3,244
|
|
||
Short-term debt
|
(92
|
)
|
|
(170
|
)
|
||
Current portion of long-term debt
|
(15
|
)
|
|
(19
|
)
|
||
Long-term debt (less current portion and debt issuance cost discounts)
|
$
|
2,825
|
|
|
$
|
3,055
|
|
|
|
|
|
(a)
|
These debt instruments were issued by Valvoline during 2016 and 2017 in connection with the separation process.
|
(b)
|
Other includes
$29 million
of debt issuance cost discounts as of
December 31, 2016
and
September 30, 2016
.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In millions)
|
|
|
|
Balance at October 1, 2016
|
$
|
168
|
|
Increases related to positions taken on items from prior years
|
4
|
|
|
Decreases related to positions taken on items from prior years
|
(2
|
)
|
|
Increases related to positions taken in the current year
|
4
|
|
|
Settlement of uncertain tax positions with tax authorities
|
(1
|
)
|
|
Balance at December 31, 2016
|
$
|
173
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other postretirement
|
||||||||||
|
Pension benefits
|
|
benefits
|
||||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
||||
Three months ended December 31
|
|
|
|
|
|
|
|
||||||||
Service cost
(a)
|
$
|
3
|
|
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Interest cost
|
23
|
|
|
31
|
|
|
1
|
|
|
2
|
|
||||
Expected return on plan assets
|
(39
|
)
|
|
(47
|
)
|
|
—
|
|
|
—
|
|
||||
Amortization of prior service credit
(a)
|
—
|
|
|
(1
|
)
|
|
(3
|
)
|
|
(4
|
)
|
||||
Actuarial gain
|
—
|
|
|
—
|
|
|
(10
|
)
|
|
—
|
|
||||
|
$
|
(13
|
)
|
|
$
|
(11
|
)
|
|
$
|
(12
|
)
|
|
$
|
(2
|
)
|
|
|
|
|
|
|
|
|
(a)
|
Activity of $0 denote values less than $1 million.
|
|
Three months ended
|
|
|
|
|
|
|
|||||||
|
December 31
|
|
Years ended September 30
|
|||||||||||
(In thousands)
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
Open claims - beginning of period
|
57
|
|
|
60
|
|
|
60
|
|
|
65
|
|
|
65
|
|
New claims filed
|
—
|
|
|
1
|
|
|
2
|
|
|
2
|
|
|
2
|
|
Claims settled
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
Claims dismissed
|
(1
|
)
|
|
(2
|
)
|
|
(5
|
)
|
|
(7
|
)
|
|
(1
|
)
|
Open claims - end of period
|
56
|
|
|
59
|
|
|
57
|
|
|
60
|
|
|
65
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
|
|
|
|
||||||||||||
|
December 31
|
|
Years ended September 30
|
||||||||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|||||
Asbestos reserve - beginning of period
|
$
|
415
|
|
|
$
|
409
|
|
|
$
|
409
|
|
|
$
|
438
|
|
|
$
|
463
|
|
Reserve adjustment
|
—
|
|
|
—
|
|
|
37
|
|
|
—
|
|
|
4
|
|
|||||
Amounts paid
|
(9
|
)
|
|
(8
|
)
|
|
(31
|
)
|
|
(29
|
)
|
|
(29
|
)
|
|||||
Asbestos reserve - end of period
|
$
|
406
|
|
|
$
|
401
|
|
|
$
|
415
|
|
|
$
|
409
|
|
|
$
|
438
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
|
|
|
|
||||||||||||
|
December 31
|
|
Years ended September 30
|
||||||||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|||||
Insurance receivable - beginning of period
|
$
|
151
|
|
|
$
|
150
|
|
|
$
|
150
|
|
|
$
|
402
|
|
|
$
|
408
|
|
Receivable adjustment
|
—
|
|
|
—
|
|
|
16
|
|
|
(3
|
)
|
|
22
|
|
|||||
Insurance settlement
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
(227
|
)
|
|
—
|
|
|||||
Amounts collected
|
(2
|
)
|
|
(5
|
)
|
|
(11
|
)
|
|
(22
|
)
|
|
(28
|
)
|
|||||
Insurance receivable - end of period
|
$
|
149
|
|
|
$
|
145
|
|
|
$
|
151
|
|
|
$
|
150
|
|
|
$
|
402
|
|
|
Three months ended
|
|
|
|
|
|
|
|||||||
|
December 31
|
|
Years ended September 30
|
|||||||||||
(In thousands)
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
Open claims - beginning of period
|
15
|
|
|
20
|
|
|
20
|
|
|
21
|
|
|
21
|
|
New claims filed
|
—
|
|
|
—
|
|
|
1
|
|
|
1
|
|
|
1
|
|
Claims dismissed
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
(2
|
)
|
|
(1
|
)
|
Open claims - end of period
|
15
|
|
|
20
|
|
|
15
|
|
|
20
|
|
|
21
|
|
|
Three months ended
|
|
|
|
|
|
|
||||||||||||
|
December 31
|
|
Years ended September 30
|
||||||||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|||||
Asbestos reserve - beginning of period
|
$
|
321
|
|
|
$
|
311
|
|
|
$
|
311
|
|
|
$
|
329
|
|
|
$
|
342
|
|
Reserve adjustment
|
—
|
|
|
—
|
|
|
25
|
|
|
4
|
|
|
10
|
|
|||||
Amounts paid
|
(3
|
)
|
|
(5
|
)
|
|
(15
|
)
|
|
(22
|
)
|
|
(23
|
)
|
|||||
Asbestos reserve - end of period
|
$
|
318
|
|
|
$
|
306
|
|
|
$
|
321
|
|
|
$
|
311
|
|
|
$
|
329
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
|
|
|
|
|
|
||||||||||||
|
December 31
|
|
Years ended September 30
|
||||||||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
2016
|
|
|
2015
|
|
|
2014
|
|
|||||
Insurance receivable - beginning of period
|
$
|
63
|
|
|
$
|
56
|
|
|
$
|
56
|
|
|
$
|
77
|
|
|
$
|
75
|
|
Receivable adjustment
|
—
|
|
|
—
|
|
|
7
|
|
|
1
|
|
|
3
|
|
|||||
Insurance settlement
|
—
|
|
|
—
|
|
|
—
|
|
|
(22
|
)
|
|
—
|
|
|||||
Amounts collected
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|||||
Insurance receivable - end of period
|
$
|
63
|
|
|
$
|
56
|
|
|
$
|
63
|
|
|
$
|
56
|
|
|
$
|
77
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Reserve - beginning of period
|
$
|
177
|
|
|
$
|
186
|
|
Disbursements
|
(7
|
)
|
|
(10
|
)
|
||
Revised obligation estimates and accretion
|
4
|
|
|
4
|
|
||
Reserve - end of period
|
$
|
174
|
|
|
$
|
180
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Environmental expense
|
$
|
4
|
|
|
$
|
4
|
|
Legal expense
|
2
|
|
|
2
|
|
||
Total expense
|
6
|
|
|
6
|
|
||
|
|
|
|
||||
Insurance receivable
(a)
|
—
|
|
|
—
|
|
||
Total expense, net of receivable activity
|
$
|
6
|
|
|
$
|
6
|
|
|
|
|
|
(a)
|
Activity of $0 denotes value less than $1 million.
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions except per share data)
|
2016
|
|
|
2015
|
|
||
Numerator
|
|
|
|
||||
Numerator for basic and diluted EPS –
|
|
|
|
||||
Income from continuing operations
|
$
|
10
|
|
|
$
|
91
|
|
Less: Income from continuing operations attributable to noncontrolling interest
|
11
|
|
|
—
|
|
||
Income (loss) from continuing operations attributable to Ashland, net of tax
|
$
|
(1
|
)
|
|
$
|
91
|
|
Denominator
|
|
|
|
|
|
||
Denominator for basic EPS – Weighted-average
|
|
|
|
|
|
||
common shares outstanding
|
62
|
|
|
65
|
|
||
Share-based awards convertible to common shares
(a)
|
—
|
|
|
1
|
|
||
Denominator for diluted EPS – Adjusted weighted-
|
|
|
|
|
|
||
average shares and assumed conversions
|
62
|
|
|
66
|
|
||
|
|
|
|
||||
EPS from continuing operations attributable to Ashland
|
|
|
|
|
|
||
Basic
|
$
|
(0.01
|
)
|
|
$
|
1.39
|
|
Diluted
|
(0.01
|
)
|
|
1.38
|
|
||
|
|
|
|
(a)
|
As a result of the loss from continuing operations attributable to Ashland during the three months ended December 31, 2016, the effect of the share-based awards convertible to common shares would be antidilutive. As such, they have been excluded from the diluted EPS calculation.
|
|
|
|
|
|
|
|
|
|
|
2016
|
|
2015
|
||||||||||||||||||||
|
|
|
|
|
|
|
|
|
Tax
|
|
|
|
|||||||||||
|
Before
|
|
|
Tax
|
|
|
Net of
|
|
|
Before
|
|
|
(expense)
|
|
|
Net of
|
|
||||||
(In millions)
|
tax
|
|
|
benefit
|
|
|
tax
|
|
|
tax
|
|
|
benefit
|
|
|
tax
|
|
||||||
Three months ended December 31
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Unrealized translation loss
|
$
|
(150
|
)
|
|
$
|
4
|
|
|
$
|
(146
|
)
|
|
$
|
(63
|
)
|
|
$
|
2
|
|
|
$
|
(61
|
)
|
Pension and postretirement obligation adjustment:
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Amortization of unrecognized prior service
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
credits included in net income
(a)
|
(3
|
)
|
|
2
|
|
|
(1
|
)
|
|
(5
|
)
|
|
2
|
|
|
(3
|
)
|
||||||
Unrealized gain on available-for-sale securities
|
—
|
|
|
—
|
|
|
—
|
|
|
9
|
|
|
(3
|
)
|
|
6
|
|
||||||
Total other comprehensive loss
|
$
|
(153
|
)
|
|
$
|
6
|
|
|
$
|
(147
|
)
|
|
$
|
(59
|
)
|
|
$
|
1
|
|
|
$
|
(58
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
(a)
|
Amortization of unrecognized prior service credits are included in the calculation of net periodic benefit costs (income) for pension and other postretirement plans. For specific financial statement captions impacted by the amortization see the table below.
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Cost of sales
|
$
|
(1
|
)
|
|
$
|
(2
|
)
|
Selling, general and administrative expense
|
(2
|
)
|
|
(3
|
)
|
||
Total amortization of unrecognized prior service credits
|
$
|
(3
|
)
|
|
$
|
(5
|
)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions - unaudited)
|
2016
|
|
|
2015
|
|
||
SALES
|
|
|
|
||||
Specialty Ingredients
|
$
|
482
|
|
|
$
|
476
|
|
Performance Materials
|
222
|
|
|
231
|
|
||
Valvoline
|
489
|
|
|
456
|
|
||
|
$
|
1,193
|
|
|
$
|
1,163
|
|
OPERATING INCOME (LOSS)
|
|
|
|
|
|
||
Specialty Ingredients
|
$
|
40
|
|
|
$
|
38
|
|
Performance Materials
|
8
|
|
|
24
|
|
||
Valvoline
|
99
|
|
|
92
|
|
||
Unallocated and other
|
(10
|
)
|
|
(3
|
)
|
||
|
$
|
137
|
|
|
$
|
151
|
|
|
|
|
|
|
|
|
|
|
Condensed Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|||||||||||
Three months ended December 31, 2016
|
|
|
|
|
|
|
|
|
|
||||||||||
(In millions)
|
Ashland Global Holdings Inc. (Parent Guarantor)
|
|
|
Ashland LLC (Issuer)
|
|
|
Other Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|||||
Sales
|
$
|
—
|
|
|
$
|
137
|
|
|
$
|
1,065
|
|
|
$
|
(9
|
)
|
|
$
|
1,193
|
|
Cost of sales
|
—
|
|
|
96
|
|
|
719
|
|
|
(8
|
)
|
|
807
|
|
|||||
Gross profit
|
—
|
|
|
41
|
|
|
346
|
|
|
(1
|
)
|
|
386
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Selling, general and administrative expense
|
8
|
|
|
32
|
|
|
199
|
|
|
—
|
|
|
239
|
|
|||||
Research and development expense
|
—
|
|
|
3
|
|
|
20
|
|
|
—
|
|
|
23
|
|
|||||
Equity and other income (loss)
|
—
|
|
|
(15
|
)
|
|
28
|
|
|
—
|
|
|
13
|
|
|||||
Operating income (loss)
|
(8
|
)
|
|
(9
|
)
|
|
155
|
|
|
(1
|
)
|
|
137
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest and other financing expense
|
—
|
|
|
34
|
|
|
98
|
|
|
—
|
|
|
132
|
|
|||||
Net loss on divestitures
|
—
|
|
|
(1
|
)
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|||||
Income (loss) from continuing operations
|
|
|
|
|
|
|
|
|
|
||||||||||
before income taxes
|
(8
|
)
|
|
(44
|
)
|
|
57
|
|
|
(1
|
)
|
|
4
|
|
|||||
Income tax expense (benefit)
|
—
|
|
|
5
|
|
|
(11
|
)
|
|
—
|
|
|
(6
|
)
|
|||||
Equity in net income (loss) of subsidiaries
|
7
|
|
|
1
|
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
|||||
Net income (loss)
|
(1
|
)
|
|
(48
|
)
|
|
68
|
|
|
(9
|
)
|
|
10
|
|
|||||
Net income attributable to noncontrolling interests
|
—
|
|
|
—
|
|
|
11
|
|
|
—
|
|
|
11
|
|
|||||
Net income (loss) attributable to Ashland
|
$
|
(1
|
)
|
|
$
|
(48
|
)
|
|
$
|
57
|
|
|
$
|
(9
|
)
|
|
$
|
(1
|
)
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Comprehensive income (loss)
|
(137
|
)
|
|
(41
|
)
|
|
(86
|
)
|
|
127
|
|
|
(137
|
)
|
|||||
Comprehensive income attributable
|
|
|
|
|
|
|
|
|
|
||||||||||
to noncontrolling interests
|
10
|
|
|
—
|
|
|
10
|
|
|
(10
|
)
|
|
10
|
|
|||||
Comprehensive income (loss) attributable
|
|
|
|
|
|
|
|
|
|
||||||||||
to Ashland
|
$
|
(147
|
)
|
|
$
|
(41
|
)
|
|
$
|
(96
|
)
|
|
$
|
137
|
|
|
$
|
(147
|
)
|
|
|
|
|
|
|
|
|
|
Condensed Statements of Comprehensive Income
|
|
|
|
|
|
|
|
|
|||||||||||
Three months ended December 31, 2015
|
|
|
|
|
|
|
|
|
|
||||||||||
(In millions)
|
Ashland Global Holdings Inc. (Parent Guarantor)
|
|
|
Ashland LLC (Issuer)
|
|
|
Other Non-Guarantor
Subsidiaries
|
|
|
Eliminations
|
|
|
Consolidated
|
|
|||||
Sales
|
$
|
—
|
|
|
$
|
156
|
|
|
$
|
1,014
|
|
|
$
|
(7
|
)
|
|
$
|
1,163
|
|
Cost of sales
|
—
|
|
|
102
|
|
|
675
|
|
|
(6
|
)
|
|
771
|
|
|||||
Gross profit
|
—
|
|
|
54
|
|
|
339
|
|
|
(1
|
)
|
|
392
|
|
|||||
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Selling, general and administrative expense
|
—
|
|
|
32
|
|
|
192
|
|
|
—
|
|
|
224
|
|
|||||
Research and development expense
|
—
|
|
|
3
|
|
|
22
|
|
|
—
|
|
|
25
|
|
|||||
Equity and other income (loss)
|
—
|
|
|
(2
|
)
|
|
10
|
|
|
—
|
|
|
8
|
|
|||||
Operating income (loss)
|
—
|
|
|
17
|
|
|
135
|
|
|
(1
|
)
|
|
151
|
|
|||||
|
|
|
|
|
|
|
|
|
|
||||||||||
Net interest and other financing expense
|
—
|
|
|
38
|
|
|
4
|
|
|
—
|
|
|
42
|
|
|||||
Net gain on divestitures
|
—
|
|
|
1
|
|
|
1
|
|
|
—
|
|
|
2
|
|
|||||
Income (loss) from continuing operations
|
|
|
|
|
|
|
|
|
|
||||||||||
before income taxes
|
—
|
|
|
(20
|
)
|
|
132
|
|
|
(1
|
)
|
|
111
|
|
|||||
Income tax expense (benefit)
|
—
|
|
|
(27
|
)
|
|
47
|
|
|
—
|
|
|
20
|
|
|||||
Equity in net income (loss) of subsidiaries
|
89
|
|
|
95
|
|
|
—
|
|
|
(184
|
)
|
|
—
|
|
|||||
Income (loss) from continuing operations
|
89
|
|
|
102
|
|
|
85
|
|
|
(185
|
)
|
|
91
|
|
|||||
Loss from discontinued operations (net of tax)
|
—
|
|
|
(1
|
)
|
|
(1
|
)
|
|
—
|
|
|
(2
|
)
|
|||||
Net income (loss)
|
$
|
89
|
|
|
$
|
101
|
|
|
$
|
84
|
|
|
$
|
(185
|
)
|
|
$
|
89
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Comprehensive income (loss)
|
$
|
31
|
|
|
$
|
100
|
|
|
$
|
27
|
|
|
$
|
(127
|
)
|
|
$
|
31
|
|
|
|
|
|
|
|
|
|
|
Condensed Balance Sheets
|
|
|
|
|
|
|
|
|
|
||||||||||
At December 31, 2016
|
|
|
|
|
|
|
|
|
|
||||||||||
(In millions) |
Ashland Global Holdings Inc. (Parent Guarantor)
|
|
|
Ashland LLC (Issuer)
|
|
|
Other Non-Guarantor
Subsidiaries |
|
|
Eliminations
|
|
|
Consolidated
|
|
|||||
ASSETS
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
$
|
—
|
|
|
$
|
148
|
|
|
$
|
556
|
|
|
$
|
—
|
|
|
$
|
704
|
|
Accounts receivable
|
—
|
|
|
47
|
|
|
811
|
|
|
—
|
|
|
858
|
|
|||||
Inventories
|
—
|
|
|
45
|
|
|
621
|
|
|
—
|
|
|
666
|
|
|||||
Other assets
|
6
|
|
|
10
|
|
|
100
|
|
|
(10
|
)
|
|
106
|
|
|||||
Total current assets
|
6
|
|
|
250
|
|
|
2,088
|
|
|
(10
|
)
|
|
2,334
|
|
|||||
Noncurrent assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Property, plant and equipment, net
|
—
|
|
|
241
|
|
|
1,945
|
|
|
—
|
|
|
2,186
|
|
|||||
Goodwill
|
—
|
|
|
141
|
|
|
2,207
|
|
|
—
|
|
|
2,348
|
|
|||||
Intangibles
|
—
|
|
|
35
|
|
|
991
|
|
|
—
|
|
|
1,026
|
|
|||||
Restricted investments
|
—
|
|
|
—
|
|
|
297
|
|
|
—
|
|
|
297
|
|
|||||
Asbestos insurance receivable
|
—
|
|
|
131
|
|
|
63
|
|
|
—
|
|
|
194
|
|
|||||
Equity and other unconsolidated investments
|
—
|
|
|
2
|
|
|
58
|
|
|
—
|
|
|
60
|
|
|||||
Investment in subsidiaries
|
2,995
|
|
|
7,503
|
|
|
—
|
|
|
(10,498
|
)
|
|
—
|
|
|||||
Deferred income taxes
|
31
|
|
|
97
|
|
|
199
|
|
|
(128
|
)
|
|
199
|
|
|||||
Intercompany receivables
|
—
|
|
|
19
|
|
|
2,539
|
|
|
(2,558
|
)
|
|
—
|
|
|||||
Other assets
|
—
|
|
|
254
|
|
|
165
|
|
|
—
|
|
|
419
|
|
|||||
Total noncurrent assets
|
3,026
|
|
|
8,423
|
|
|
8,464
|
|
|
(13,184
|
)
|
|
6,729
|
|
|||||
Total assets
|
$
|
3,032
|
|
|
$
|
8,673
|
|
|
$
|
10,552
|
|
|
$
|
(13,194
|
)
|
|
$
|
9,063
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Short-term debt
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
92
|
|
|
$
|
—
|
|
|
$
|
92
|
|
Current portion of long-term debt
|
—
|
|
|
—
|
|
|
15
|
|
|
—
|
|
|
15
|
|
|||||
Accounts payable and other accrued liabilities
|
—
|
|
|
222
|
|
|
697
|
|
|
(10
|
)
|
|
909
|
|
|||||
Total current liabilities
|
—
|
|
|
222
|
|
|
804
|
|
|
(10
|
)
|
|
1,016
|
|
|||||
Noncurrent liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Long-term debt
|
—
|
|
|
2,116
|
|
|
709
|
|
|
—
|
|
|
2,825
|
|
|||||
Employee benefit obligations
|
—
|
|
|
38
|
|
|
1,002
|
|
|
—
|
|
|
1,040
|
|
|||||
Asbestos litigation reserve
|
—
|
|
|
371
|
|
|
303
|
|
|
—
|
|
|
674
|
|
|||||
Deferred income taxes
|
—
|
|
|
—
|
|
|
197
|
|
|
(128
|
)
|
|
69
|
|
|||||
Intercompany payables
|
31
|
|
|
2,508
|
|
|
19
|
|
|
(2,558
|
)
|
|
—
|
|
|||||
Other liabilities
|
—
|
|
|
220
|
|
|
218
|
|
|
—
|
|
|
438
|
|
|||||
Total noncurrent liabilities
|
31
|
|
|
5,253
|
|
|
2,448
|
|
|
(2,686
|
)
|
|
5,046
|
|
|||||
Equity
|
|
|
|
|
|
|
|
|
|
||||||||||
Total Ashland stockholders’ equity
|
3,001
|
|
|
3,198
|
|
|
7,474
|
|
|
(10,498
|
)
|
|
3,175
|
|
|||||
Noncontrolling interests
|
—
|
|
|
—
|
|
|
(174
|
)
|
|
—
|
|
|
(174
|
)
|
|||||
Total equity
|
3,001
|
|
|
3,198
|
|
|
7,300
|
|
|
(10,498
|
)
|
|
3,001
|
|
|||||
Total liabilities and equity
|
$
|
3,032
|
|
|
$
|
8,673
|
|
|
$
|
10,552
|
|
|
$
|
(13,194
|
)
|
|
$
|
9,063
|
|
|
|
|
|
|
|
|
|
|
Condensed Balance Sheets
|
|
|
|
|
|
|
|
|
|
||||||||||
At September 30, 2016
|
|
|
|
|
|
|
|
|
|
||||||||||
(In millions) |
Ashland Global Holdings Inc. (Parent Guarantor)
|
|
|
Ashland LLC (Issuer)
|
|
|
Other Non-Guarantor
Subsidiaries |
|
|
Eliminations
|
|
|
Consolidated
|
|
|||||
ASSETS
|
|
|
|
|
|
|
|
|
|
||||||||||
Current assets
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
$
|
—
|
|
|
$
|
76
|
|
|
$
|
1,112
|
|
|
$
|
—
|
|
|
$
|
1,188
|
|
Accounts receivable
|
—
|
|
|
18
|
|
|
876
|
|
|
—
|
|
|
894
|
|
|||||
Inventories
|
—
|
|
|
42
|
|
|
629
|
|
|
—
|
|
|
671
|
|
|||||
Other assets
|
7
|
|
|
16
|
|
|
98
|
|
|
(8
|
)
|
|
113
|
|
|||||
Total current assets
|
7
|
|
|
152
|
|
|
2,715
|
|
|
(8
|
)
|
|
2,866
|
|
|||||
Noncurrent assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Property, plant and equipment, net
|
—
|
|
|
246
|
|
|
1,978
|
|
|
—
|
|
|
2,224
|
|
|||||
Goodwill
|
—
|
|
|
141
|
|
|
2,260
|
|
|
—
|
|
|
2,401
|
|
|||||
Intangibles
|
—
|
|
|
35
|
|
|
1,029
|
|
|
—
|
|
|
1,064
|
|
|||||
Restricted investments
|
—
|
|
|
—
|
|
|
292
|
|
|
—
|
|
|
292
|
|
|||||
Asbestos insurance receivable
|
—
|
|
|
133
|
|
|
63
|
|
|
—
|
|
|
196
|
|
|||||
Equity and other unconsolidated investments
|
—
|
|
|
2
|
|
|
55
|
|
|
—
|
|
|
57
|
|
|||||
Investment in subsidiaries
|
3,127
|
|
|
7,597
|
|
|
—
|
|
|
(10,724
|
)
|
|
—
|
|
|||||
Deferred income taxes
|
31
|
|
|
97
|
|
|
146
|
|
|
(97
|
)
|
|
177
|
|
|||||
Intercompany receivables
|
—
|
|
|
5
|
|
|
2,264
|
|
|
(2,269
|
)
|
|
—
|
|
|||||
Other assets
|
—
|
|
|
253
|
|
|
167
|
|
|
—
|
|
|
420
|
|
|||||
Total noncurrent assets
|
3,158
|
|
|
8,509
|
|
|
8,254
|
|
|
(13,090
|
)
|
|
6,831
|
|
|||||
Total assets
|
$
|
3,165
|
|
|
$
|
8,661
|
|
|
$
|
10,969
|
|
|
$
|
(13,098
|
)
|
|
$
|
9,697
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Short-term debt
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
170
|
|
|
$
|
—
|
|
|
$
|
170
|
|
Current portion of long-term debt
|
—
|
|
|
—
|
|
|
19
|
|
|
—
|
|
|
19
|
|
|||||
Accounts payable and other accrued liabilities
|
—
|
|
|
244
|
|
|
791
|
|
|
(8
|
)
|
|
1,027
|
|
|||||
Total current liabilities
|
—
|
|
|
244
|
|
|
980
|
|
|
(8
|
)
|
|
1,216
|
|
|||||
Noncurrent liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Long-term debt
|
—
|
|
|
2,182
|
|
|
873
|
|
|
—
|
|
|
3,055
|
|
|||||
Employee benefit obligations
|
—
|
|
|
44
|
|
|
1,036
|
|
|
—
|
|
|
1,080
|
|
|||||
Asbestos litigation reserve
|
—
|
|
|
381
|
|
|
305
|
|
|
—
|
|
|
686
|
|
|||||
Deferred income taxes
|
—
|
|
|
—
|
|
|
166
|
|
|
(97
|
)
|
|
69
|
|
|||||
Intercompany payables
|
—
|
|
|
2,264
|
|
|
5
|
|
|
(2,269
|
)
|
|
—
|
|
|||||
Other liabilities
|
—
|
|
|
220
|
|
|
206
|
|
|
—
|
|
|
426
|
|
|||||
Total noncurrent liabilities
|
—
|
|
|
5,091
|
|
|
2,591
|
|
|
(2,366
|
)
|
|
5,316
|
|
|||||
Equity
|
|
|
|
|
|
|
|
|
|
||||||||||
Total Ashland stockholders’ equity
|
3,165
|
|
|
3,326
|
|
|
7,580
|
|
|
(10,724
|
)
|
|
3,347
|
|
|||||
Noncontrolling interest
|
—
|
|
|
—
|
|
|
(182
|
)
|
|
—
|
|
|
(182
|
)
|
|||||
Total equity
|
3,165
|
|
|
3,326
|
|
|
7,398
|
|
|
(10,724
|
)
|
|
3,165
|
|
|||||
Total liabilities and equity
|
$
|
3,165
|
|
|
$
|
8,661
|
|
|
$
|
10,969
|
|
|
$
|
(13,098
|
)
|
|
$
|
9,697
|
|
|
|
|
|
|
|
|
|
|
Condensed Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
||||||||||
Three months ended December 31, 2016
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
(In millions) |
Ashland Global Holdings Inc. (Parent Guarantor)
|
|
|
Ashland LLC (Issuer)
|
|
|
Other Non-Guarantor
Subsidiaries |
|
|
Eliminations
|
|
|
Consolidated
|
|
|||||
Total cash flows provided (used) by operating
|
|
|
|
|
|
|
|
|
|
||||||||||
activities from continuing operations
|
$
|
—
|
|
|
$
|
(83
|
)
|
|
$
|
95
|
|
|
$
|
—
|
|
|
$
|
12
|
|
Cash flows provided (used) by investing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
activities from continuing operations
|
|
|
|
|
|
|
|
|
|
||||||||||
Additions to property, plant and equipment
|
—
|
|
|
(3
|
)
|
|
(40
|
)
|
|
—
|
|
|
(43
|
)
|
|||||
Intercompany dividends
|
8
|
|
|
8
|
|
|
—
|
|
|
(16
|
)
|
|
—
|
|
|||||
Net purchases of funds restricted for
|
|
|
|
|
|
|
|
|
|
||||||||||
specific transactions
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|||||
Other investing activities, net
|
—
|
|
|
4
|
|
|
—
|
|
|
—
|
|
|
4
|
|
|||||
Total cash flows provided (used) by investing
|
|
|
|
|
|
|
|
|
|
||||||||||
activities from continuing operations
|
8
|
|
|
7
|
|
|
(40
|
)
|
|
(16
|
)
|
|
(41
|
)
|
|||||
Cash flows provided (used) by financing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
activities from continuing operations
|
|
|
|
|
|
|
|
|
|
||||||||||
Repayment of long-term debt
|
—
|
|
|
(65
|
)
|
|
(253
|
)
|
|
—
|
|
|
(318
|
)
|
|||||
Premium on long-term debt repayment
|
—
|
|
|
(1
|
)
|
|
(4
|
)
|
|
—
|
|
|
(5
|
)
|
|||||
Repayment from short-term debt
|
—
|
|
|
—
|
|
|
(78
|
)
|
|
—
|
|
|
(78
|
)
|
|||||
Cash dividends paid
|
(24
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(24
|
)
|
|||||
Distributions to noncontrolling interest
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
(2
|
)
|
|||||
Intercompany dividends
|
(8
|
)
|
|
—
|
|
|
(8
|
)
|
|
16
|
|
|
—
|
|
|||||
Other intercompany activity, net
|
24
|
|
|
231
|
|
|
(255
|
)
|
|
—
|
|
|
—
|
|
|||||
Other financing activities, net
|
—
|
|
|
(7
|
)
|
|
(1
|
)
|
|
—
|
|
|
(8
|
)
|
|||||
Total cash flows provided (used) by financing
|
|
|
|
|
|
|
|
|
|
||||||||||
activities from continuing operations
|
(8
|
)
|
|
158
|
|
|
(601
|
)
|
|
16
|
|
|
(435
|
)
|
|||||
Cash provided (used) by continuing operations
|
—
|
|
|
82
|
|
|
(546
|
)
|
|
—
|
|
|
(464
|
)
|
|||||
Cash used by discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Operating cash flows
|
—
|
|
|
(10
|
)
|
|
(2
|
)
|
|
—
|
|
|
(12
|
)
|
|||||
Investing cash flows
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total cash used by discontinued operations
|
—
|
|
|
(10
|
)
|
|
(2
|
)
|
|
—
|
|
|
(12
|
)
|
|||||
Effect of currency exchange rate changes on
|
|
|
|
|
|
|
|
|
|
||||||||||
cash and cash equivalents
|
—
|
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
|
(8
|
)
|
|||||
Increase (decrease) in cash and cash equivalents
|
—
|
|
|
72
|
|
|
(556
|
)
|
|
—
|
|
|
(484
|
)
|
|||||
Cash and cash equivalents - beginning of year
|
—
|
|
|
76
|
|
|
1,112
|
|
|
—
|
|
|
1,188
|
|
|||||
Cash and cash equivalents - end of year
|
$
|
—
|
|
|
$
|
148
|
|
|
$
|
556
|
|
|
$
|
—
|
|
|
$
|
704
|
|
|
|
|
|
|
|
|
|
|
Condensed Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
||||||||||
Three months ended December 31, 2015
|
|
|
|
|
|
|
|
|
|
|
|
||||||||
(In millions) |
Ashland Global Holdings Inc. (Parent Guarantor)
|
|
|
Ashland LLC (Issuer)
|
|
|
Other Non-Guarantor
Subsidiaries |
|
|
Eliminations
|
|
|
Consolidated
|
|
|||||
Total cash flows provided (used) by operating
|
|
|
|
|
|
|
|
|
|
||||||||||
activities from continuing operations
|
$
|
—
|
|
|
$
|
(123
|
)
|
|
$
|
189
|
|
|
$
|
—
|
|
|
$
|
66
|
|
Cash flows provided (used) by investing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
activities from continuing operations
|
|
|
|
|
|
|
|
|
|
||||||||||
Additions to property, plant and equipment
|
—
|
|
|
(2
|
)
|
|
(51
|
)
|
|
—
|
|
|
(53
|
)
|
|||||
Purchase of operations - net of cash acquired
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
(4
|
)
|
|||||
Reimbursements from restricted investments
|
—
|
|
|
7
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|||||
Other investing activities, net
|
—
|
|
|
5
|
|
|
1
|
|
|
—
|
|
|
6
|
|
|||||
Total cash flows provided (used) by investing
|
|
|
|
|
|
|
|
|
|
||||||||||
activities from continuing operations
|
—
|
|
|
10
|
|
|
(54
|
)
|
|
—
|
|
|
(44
|
)
|
|||||
Cash flows provided (used) by financing
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
activities from continuing operations
|
|
|
|
|
|
|
|
|
|
||||||||||
Repayment of long-term debt
|
—
|
|
|
(14
|
)
|
|
—
|
|
|
—
|
|
|
(14
|
)
|
|||||
Proceeds (repayment) from short-term debt
|
—
|
|
|
409
|
|
|
(90
|
)
|
|
—
|
|
|
319
|
|
|||||
Repurchase of common stock
|
—
|
|
|
(500
|
)
|
|
—
|
|
|
—
|
|
|
(500
|
)
|
|||||
Cash dividends paid
|
—
|
|
|
(24
|
)
|
|
—
|
|
|
—
|
|
|
(24
|
)
|
|||||
Other intercompany activity, net
|
—
|
|
|
233
|
|
|
(233
|
)
|
|
—
|
|
|
—
|
|
|||||
Total cash flows provided (used) by financing
|
|
|
|
|
|
|
|
|
|
||||||||||
activities from continuing operations
|
—
|
|
|
104
|
|
|
(323
|
)
|
|
—
|
|
|
(219
|
)
|
|||||
Cash used by continuing operations
|
—
|
|
|
(9
|
)
|
|
(188
|
)
|
|
—
|
|
|
(197
|
)
|
|||||
Cash used by discontinued operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Operating cash flows
|
—
|
|
|
(5
|
)
|
|
(5
|
)
|
|
—
|
|
|
(10
|
)
|
|||||
Investing cash flows
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
Total cash used by discontinued operations
|
—
|
|
|
(5
|
)
|
|
(5
|
)
|
|
—
|
|
|
(10
|
)
|
|||||
Effect of currency exchange rate changes on
|
|
|
|
|
|
|
|
|
|
||||||||||
cash and cash equivalents
|
—
|
|
|
—
|
|
|
(11
|
)
|
|
—
|
|
|
(11
|
)
|
|||||
Decrease in cash and cash equivalents
|
—
|
|
|
(14
|
)
|
|
(204
|
)
|
|
—
|
|
|
(218
|
)
|
|||||
Cash and cash equivalents - beginning of year
|
—
|
|
|
21
|
|
|
1,236
|
|
|
—
|
|
|
1,257
|
|
|||||
Cash and cash equivalents - end of year
|
$
|
—
|
|
|
$
|
7
|
|
|
$
|
1,032
|
|
|
$
|
—
|
|
|
$
|
1,039
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||
|
December 31
|
||||
Sales by Geography
|
2016
|
|
|
2015
|
|
North America
(a)
|
54
|
%
|
|
53
|
%
|
Europe
|
21
|
%
|
|
23
|
%
|
Asia Pacific
|
18
|
%
|
|
17
|
%
|
Latin America & other
|
7
|
%
|
|
7
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
|
|
|
Three months ended
|
||||
|
December 31
|
||||
Sales by Reportable Segment
|
2016
|
|
|
2015
|
|
Specialty Ingredients
|
40
|
%
|
|
41
|
%
|
Performance Materials
|
19
|
%
|
|
20
|
%
|
Valvoline
|
41
|
%
|
|
39
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
•
|
EBITDA - net income, plus income tax expense (benefit), net interest and other financing expenses, and depreciation and amortization.
|
•
|
Adjusted EBITDA - EBITDA adjusted for noncontrolling interests, discontinued operations, net gain (loss) on acquisitions and divestitures, other income and (expense) and key items (including the remeasurement gains and losses related to pension and other postretirement plans).
|
•
|
Adjusted EBITDA margin - Adjusted EBITDA divided by sales.
|
•
|
Free cash flow - operating cash flows less capital expenditures and certain other adjustments as applicable.
|
|
|
|
|
|
|
|
|
|
•
|
Ashland’s net income (loss) attributable to Ashland amounted to a loss of
$1 million
and income of
$89 million
for the three months ended
December 31, 2016
and
2015
, respectively, or a loss of
$0.01
and income of
$1.35
diluted earnings per share, respectively.
|
•
|
Ashland’s net income attributable to noncontrolling interest amounted to
$11 million
for the three months ended
December 31, 2016
and reflects the noncontrolling interest of Valvoline Inc.
|
•
|
Income from continuing operations, which excludes results from discontinued operations, amounted to
$10 million
and
$91 million
for the three months ended
December 31, 2016
and
2015
, respectively.
|
•
|
The effective income tax benefit rate of
150%
and expense rate of
18%
for the three months ended
December 31, 2016
and
2015
, respectively, were both affected by certain discrete items.
|
|
|
|
|
|
|
|
|
|
•
|
Ashland incurred pretax net interest and other financing expense of
$132 million
and
$42 million
for the three months ended
December 31, 2016
and
2015
, respectively. The current quarter was impacted by $92 million of net charges associated with current quarter debt financing activity.
|
•
|
Operating income was
$137 million
and
$151 million
for the three months ended
December 31, 2016
and
2015
, respectively.
|
◦
|
$28 million
and $6 million of costs related to the separation of Valvoline during the three months ended
December 31, 2016
and
2015
, respectively;
|
◦
|
$5 million reversal of the severance accrual and $2 million of accelerated depreciation related to a restructuring plan within an existing manufacturing facility during the three months ended
December 31, 2015
;
|
•
|
Remeasurement gain of
$10 million
associated with the discontinuation of certain post-employment health and life insurance benefits during the three months ended
December 31, 2016
; and
|
•
|
$5 million and $10 million charges for legal reserves during the three months ended
December 31, 2016
and
2015
, respectively.
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Net income
|
$
|
10
|
|
|
$
|
89
|
|
Income tax expense (benefit)
|
(6
|
)
|
|
20
|
|
||
Net interest and other financing expense
|
132
|
|
|
42
|
|
||
Depreciation and amortization
(a)
|
77
|
|
|
81
|
|
||
EBITDA
|
213
|
|
|
232
|
|
||
Net income attributable to noncontrolling interest
|
(11
|
)
|
|
—
|
|
||
Adjusted EBITDA adjustments attributable to noncontrolling interest
(b)
|
(10
|
)
|
|
—
|
|
||
Loss from discontinued operations (net of tax)
|
—
|
|
|
2
|
|
||
Separation, restructuring and other costs, net
|
28
|
|
|
1
|
|
||
Gain on post-employment plan remeasurement
|
(10
|
)
|
|
—
|
|
||
Legal reserve
|
5
|
|
|
10
|
|
||
Accelerated depreciation
|
—
|
|
|
2
|
|
||
Adjusted EBITDA
(c)
|
$
|
215
|
|
|
$
|
247
|
|
|
|
|
|
(a)
|
Excludes
$2 million
of accelerated depreciation for the three months ended December 31,
2015
.
|
(b)
|
Includes certain items attributable to the approximately 17% noncontrolling interest in Valvoline Inc. such as income tax expense, net interest and other financing expense, depreciation and amortization, separation costs and the gain on post-employment plan remeasurement.
|
(c)
|
Includes $12 million and
$13 million
during the
three
months ended
December 31, 2016
and
2015
, respectively, of net periodic pension and other postretirement income recognized ratably through the fiscal year. This income is comprised of service cost, interest cost, expected return on plan assets, and amortization of prior service credit and is disclosed in further detail in Note J of the Notes to Condensed Consolidated Financial Statements.
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Sales
|
$
|
1,193
|
|
|
$
|
1,163
|
|
|
$
|
30
|
|
|
Three months ended
|
|
||
(In millions)
|
December 31, 2016
|
|
||
Volume
|
|
$
|
55
|
|
Pricing
|
|
(29
|
)
|
|
Product mix
|
|
(4
|
)
|
|
Currency exchange
|
|
(5
|
)
|
|
Acquisitions and divestitures
|
|
13
|
|
|
Change in sales
|
|
$
|
30
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Cost of sales
|
$
|
807
|
|
|
$
|
771
|
|
|
$
|
36
|
|
Gross profit as a percent of sales
|
32.4
|
%
|
|
33.7
|
%
|
|
|
|
|
Three months ended
|
|
||
(In millions)
|
December 31, 2016
|
|
||
Changes in:
|
|
|
||
Volume
|
|
$
|
38
|
|
Acquisition and divestitures
|
|
9
|
|
|
Currency exchange
|
|
(4
|
)
|
|
Production costs
|
|
(4
|
)
|
|
Product mix
|
|
(3
|
)
|
|
Pension and other postretirement benefit plans expense (income)
|
|
(3
|
)
|
|
Severance and other costs
|
|
5
|
|
|
Accelerated depreciation
|
|
(2
|
)
|
|
Change in cost of sales
|
|
$
|
36
|
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Selling, general and administrative expense
|
$
|
239
|
|
|
$
|
224
|
|
|
$
|
15
|
|
As a percent of sales
|
20.0
|
%
|
|
19.3
|
%
|
|
|
|
•
|
$28 million of costs related to the separation of Valvoline during the current quarter compared to $6 million in the prior year quarter;
|
•
|
$5 million and $10 million charges for legal reserves during the current quarter and prior year quarter, respectively; and
|
|
|
|
|
|
|
|
|
|
•
|
a $6 million gain on the remeasurement of certain post-employment health and life insurance benefits during the current quarter.
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Research and development expense
|
$
|
23
|
|
|
$
|
25
|
|
|
$
|
(2
|
)
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Equity and other income
|
|
|
|
|
|
|
|
|
|||
Equity income
|
$
|
4
|
|
|
$
|
4
|
|
|
$
|
—
|
|
Other income
|
9
|
|
|
4
|
|
|
5
|
|
|||
|
$
|
13
|
|
|
$
|
8
|
|
|
$
|
5
|
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Net interest and other financing expense (income)
|
|
|
|
|
|
||||||
Interest expense
|
$
|
135
|
|
|
$
|
43
|
|
|
$
|
92
|
|
Interest income
|
(1
|
)
|
|
(1
|
)
|
|
—
|
|
|||
Available-for-sale securities income
|
(3
|
)
|
|
(2
|
)
|
|
(1
|
)
|
|||
Other financing costs
|
1
|
|
|
2
|
|
|
(1
|
)
|
|||
|
$
|
132
|
|
|
$
|
42
|
|
|
$
|
90
|
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Net gain (loss) on divestitures
|
|
|
|
|
|
||||||
MAP Transaction adjustments
|
$
|
(1
|
)
|
|
$
|
1
|
|
|
$
|
(2
|
)
|
Castings Solutions joint venture
|
—
|
|
|
1
|
|
|
(1
|
)
|
|||
|
$
|
(1
|
)
|
|
$
|
2
|
|
|
$
|
(3
|
)
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Income tax expense (benefit)
|
$
|
(6
|
)
|
|
$
|
20
|
|
|
$
|
(26
|
)
|
Effective tax rate
|
(150
|
)%
|
|
18
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Loss from discontinued operations (net of tax)
|
|
|
|
|
|
||||||
Water Technologies
|
$
|
—
|
|
|
$
|
(2
|
)
|
|
$
|
2
|
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
|
$
|
2
|
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Net income attributable to noncontrolling interest
|
$
|
11
|
|
|
$
|
—
|
|
|
$
|
11
|
|
|
Three months ended December 31
|
||||||||||
(In millions)
|
2016
|
|
|
2015
|
|
|
Change
|
|
|||
Other comprehensive income (loss) (net of taxes)
|
|
|
|
|
|
||||||
Unrealized translation loss
|
$
|
(146
|
)
|
|
$
|
(61
|
)
|
|
$
|
(85
|
)
|
Pension and postretirement obligation adjustment
|
(1
|
)
|
|
(3
|
)
|
|
2
|
|
|||
Unrealized gain on available-for-sale securities
|
—
|
|
|
6
|
|
|
(6
|
)
|
|||
|
$
|
(147
|
)
|
|
$
|
(58
|
)
|
|
$
|
(89
|
)
|
•
|
For the three months ended
December 31, 2016
, other comprehensive loss, net of tax, from foreign currency translation adjustments was
$146 million
compared to
$61 million
for the three months ended
December 31, 2015
, mainly as a result of the strengthening of the U.S. Dollar against other global currencies, such as the Euro. The fluctuations in unrealized translation gains and losses is primarily due to translating foreign subsidiary financial statements from local currencies to U.S. Dollars.
|
•
|
Pension and postretirement obligation adjustment was
$1 million
compared to
$3 million
for the three months ended
December 31, 2016
and
2015
, respectively. These amounts of unrecognized prior service credits, net of tax, related to pension and other postretirement benefit plans were amortized and reclassified into net income.
|
|
|
|
|
|
|
|
|
|
•
|
Unrealized gain of
$6 million
on available-for-sale securities, net of tax, related to restricted investments, were recognized within other comprehensive loss during the three months ended December 31,
2015
.
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Sales
|
|
|
|
||||
Specialty Ingredients
|
$
|
482
|
|
|
$
|
476
|
|
Performance Materials
|
222
|
|
|
231
|
|
||
Valvoline
|
489
|
|
|
456
|
|
||
|
$
|
1,193
|
|
|
$
|
1,163
|
|
Operating income (loss)
|
|
|
|
|
|
||
Specialty Ingredients
|
$
|
40
|
|
|
$
|
38
|
|
Performance Materials
|
8
|
|
|
24
|
|
||
Valvoline
|
99
|
|
|
92
|
|
||
Unallocated and other
|
(10
|
)
|
|
(3
|
)
|
||
|
$
|
137
|
|
|
$
|
151
|
|
Depreciation and amortization
|
|
|
|
|
|
||
Specialty Ingredients
|
$
|
55
|
|
|
$
|
61
|
|
Performance Materials
|
13
|
|
|
13
|
|
||
Valvoline
|
9
|
|
|
9
|
|
||
|
$
|
77
|
|
|
$
|
83
|
|
Operating information
|
|
|
|
|
|
||
Specialty Ingredients
|
|
|
|
|
|
||
Sales per shipping day
|
$
|
7.9
|
|
|
$
|
7.7
|
|
Metric tons sold (thousands)
|
72.6
|
|
|
68.7
|
|
||
Gross profit as a percent of sales
(a)
|
32.0
|
%
|
|
32.9
|
%
|
||
Performance Materials
|
|
|
|
|
|||
Sales per shipping day
|
$
|
3.6
|
|
|
$
|
3.7
|
|
Metric tons sold (thousands)
|
110.6
|
|
|
106.2
|
|
||
Gross profit as a percent of sales
(a)
|
15.4
|
%
|
|
22.1
|
%
|
||
Valvoline
|
|
|
|
|
|
||
Lubricant sales gallons
|
43.1
|
|
|
40.4
|
|
||
Premium lubricants (percent of U.S. branded volumes)
|
47.2
|
%
|
|
43.0
|
%
|
||
Gross profit as a percent of sales
(a)
|
37.9
|
%
|
|
38.3
|
%
|
||
|
|
|
|
(a)
|
Gross profit is defined as sales, less cost of sales divided by sales.
|
|
Three months ended December 31, 2016
|
|||||||
Sales by Geography
|
Specialty Ingredients
|
|
Performance Materials
|
|
Valvoline
|
|||
North America
|
39
|
%
|
|
43
|
%
|
|
75
|
%
|
Europe
|
29
|
%
|
|
36
|
%
|
|
7
|
%
|
Asia Pacific
|
22
|
%
|
|
16
|
%
|
|
14
|
%
|
Latin America & other
|
10
|
%
|
|
5
|
%
|
|
4
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
Three months ended December 31, 2015
|
|||||||
Sales by Geography
|
Specialty Ingredients
|
|
Performance Materials
|
|
Valvoline
|
|||
North America
|
38
|
%
|
|
40
|
%
|
|
75
|
%
|
Europe
|
32
|
%
|
|
39
|
%
|
|
7
|
%
|
Asia Pacific
|
20
|
%
|
|
14
|
%
|
|
14
|
%
|
Latin America & other
|
10
|
%
|
|
7
|
%
|
|
4
|
%
|
|
100
|
%
|
|
100
|
%
|
|
100
|
%
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Operating income
|
$
|
40
|
|
|
$
|
38
|
|
Depreciation and amortization
(a)
|
55
|
|
|
59
|
|
||
EBITDA
|
95
|
|
|
97
|
|
||
Severance
|
—
|
|
|
(5
|
)
|
||
Accelerated depreciation
|
—
|
|
|
2
|
|
||
Adjusted EBITDA
|
$
|
95
|
|
|
$
|
94
|
|
|
|
|
|
(a)
|
Excludes
$2 million
of accelerated depreciation for the three months ended
December 31, 2015
.
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Operating income
|
$
|
8
|
|
|
$
|
24
|
|
Depreciation and amortization
|
13
|
|
|
13
|
|
||
EBITDA
|
$
|
21
|
|
|
$
|
37
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Operating income
|
$
|
99
|
|
|
$
|
92
|
|
Depreciation and amortization
|
9
|
|
|
9
|
|
||
EBITDA
|
$
|
108
|
|
|
$
|
101
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Pension and other postretirement net periodic income
|
|
|
|
||||
(excluding service cost)
|
$
|
18
|
|
|
$
|
19
|
|
Gain on post-employment plan remeasurement
|
10
|
|
|
—
|
|
||
Restructuring activities (includes separation and severance costs)
|
(28
|
)
|
|
(6
|
)
|
||
Environmental expense for divested businesses
|
(4
|
)
|
|
(6
|
)
|
||
Legal reserve
|
(5
|
)
|
|
(10
|
)
|
||
Other expense
|
(1
|
)
|
|
—
|
|
||
Total expense
|
$
|
(10
|
)
|
|
$
|
(3
|
)
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Cash provided (used) by:
|
|
|
|
||||
Operating activities from continuing operations
|
$
|
12
|
|
|
$
|
66
|
|
Investing activities from continuing operations
|
(41
|
)
|
|
(44
|
)
|
||
Financing activities from continuing operations
|
(435
|
)
|
|
(219
|
)
|
||
Discontinued operations
|
(12
|
)
|
|
(10
|
)
|
||
Effect of currency exchange rate changes on cash and cash equivalents
|
(8
|
)
|
|
(11
|
)
|
||
Net decrease in cash and cash equivalents
|
$
|
(484
|
)
|
|
$
|
(218
|
)
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Cash flows provided (used) by operating activities from continuing operations
|
|
|
|
||||
Net income
|
$
|
10
|
|
|
$
|
89
|
|
Loss from discontinued operations (net of tax)
|
—
|
|
|
2
|
|
||
Adjustments to reconcile income from continuing operations to
|
|
|
|
|
|
||
cash flows from operating activities
|
|
|
|
|
|
||
Depreciation and amortization
|
77
|
|
|
83
|
|
||
Original issue discount and debt issuance cost amortization
|
95
|
|
|
3
|
|
||
Deferred income taxes
|
2
|
|
|
3
|
|
||
Equity income from affiliates
|
(4
|
)
|
|
(4
|
)
|
||
Distributions from equity affiliates
|
—
|
|
|
5
|
|
||
Stock based compensation expense
|
6
|
|
|
8
|
|
||
Gain on early retirement of debt
|
(3
|
)
|
|
—
|
|
||
Gain on available-for-sale securities
|
(3
|
)
|
|
(2
|
)
|
||
Net loss (gain) on divestitures
|
1
|
|
|
(2
|
)
|
||
Pension contributions
|
(3
|
)
|
|
(4
|
)
|
||
Gain on post-employment plan remeasurement
|
(10
|
)
|
|
—
|
|
||
Change in operating assets and liabilities
(a)
|
(156
|
)
|
|
(115
|
)
|
||
Total cash flows provided by operating activities from continuing operations
|
$
|
12
|
|
|
$
|
66
|
|
|
|
|
|
•
|
Accounts receivable - The cash inflows of $47 million and $126 million during the current and prior year quarters, respectively, were primarily due to collections in excess of sales during the first quarter of each fiscal year compared to the prior fiscal year.
|
•
|
Inventory - The current quarter had a cash inflow of $14 million compared to a cash outflow of $5 million during the prior year quarter. The cash inflow during the current quarter was primarily a result of production management within the Specialty Ingredients reportable segment.
|
•
|
Trade and other payables - The cash outflows of $107 million and $195 million during the current and prior year quarters, respectively, were primarily driven by seasonal declines in trade payables, and incentive compensation payouts to employees and certain Valvoline separation payments from the prior year paid during the first quarter of the fiscal year.
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Cash flows provided (used) by investing activities from continuing operations
|
|
|
|
||||
Additions to property, plant and equipment
|
$
|
(43
|
)
|
|
$
|
(53
|
)
|
Proceeds from disposal of property, plant and equipment
|
—
|
|
|
1
|
|
||
Purchase of operations - net of cash acquired
|
—
|
|
|
(4
|
)
|
||
Uses from sale of operations or equity investments
|
—
|
|
|
(2
|
)
|
||
Net purchase of funds restricted for specific transactions
|
(2
|
)
|
|
—
|
|
||
Reimbursements from restricted investments
|
—
|
|
|
7
|
|
||
Proceeds from the settlement of derivative instruments
|
4
|
|
|
7
|
|
||
Total cash flows used by investing activities from continuing operations
|
$
|
(41
|
)
|
|
$
|
(44
|
)
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Cash flows provided (used) by financing activities from continuing operations
|
|
|
|
||||
Repayment of long-term debt
|
$
|
(318
|
)
|
|
$
|
(14
|
)
|
Premium on long-term debt repayment
|
(5
|
)
|
|
—
|
|
||
Proceeds (repayment) from short-term debt
|
(78
|
)
|
|
319
|
|
||
Repurchase of common stock
|
—
|
|
|
(500
|
)
|
||
Debt issuance costs
|
(4
|
)
|
|
—
|
|
||
Cash dividends paid
|
(24
|
)
|
|
(24
|
)
|
||
Distributions to noncontrolling interest
|
(2
|
)
|
|
—
|
|
||
Excess tax benefits related to share-based payments
|
(4
|
)
|
|
—
|
|
||
Total cash flows used by financing activities from continuing operations
|
$
|
(435
|
)
|
|
$
|
(219
|
)
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Cash used by discontinued operations
|
|
|
|
||||
Operating cash flows
|
$
|
(12
|
)
|
|
$
|
(10
|
)
|
Investing cash flows
|
—
|
|
|
—
|
|
||
Total cash used by discontinued operations
|
$
|
(12
|
)
|
|
$
|
(10
|
)
|
|
|
|
|
|
|
|
|
|
|
Three months ended
|
||||||
|
December 31
|
||||||
(In millions)
|
2016
|
|
|
2015
|
|
||
Cash flows provided by operating activities from continuing operations
|
$
|
12
|
|
|
$
|
66
|
|
Adjustments:
|
|
|
|
|
|
||
Additions to property, plant and equipment
|
(43
|
)
|
|
(53
|
)
|
||
Free cash flows
|
$
|
(31
|
)
|
|
$
|
13
|
|
|
December 31
|
|
|
September 30
|
|
||
(In millions)
|
2016
|
|
|
2016
|
|
||
Cash and cash equivalents
|
$
|
704
|
|
|
$
|
1,188
|
|
|
|
|
|
||||
Unused borrowing capacity
|
|
|
|
|
|
||
2015 Revolving credit facility
|
$
|
742
|
|
|
$
|
742
|
|
2016 Revolving credit facility
(a)
|
428
|
|
|
435
|
|
||
2012 Accounts receivable securitization facility
|
75
|
|
|
80
|
|
||
2017 Accounts receivable securitization facility
(a)
|
50
|
|
|
—
|
|
||
|
|
|
|
(a)
|
The 2016 revolving credit facility and 2017 accounts receivable securitization facility were executed by Valvoline in connection with the separation process.
|
|
December 31
|
|
|
September 30
|
|
||
(In millions)
|
2016
|
|
|
2016
|
|
||
Short-term debt
|
$
|
92
|
|
|
$
|
170
|
|
Long-term debt (including current portion and debt issuance cost discounts)
(a)
|
2,840
|
|
|
3,074
|
|
||
Total debt
|
$
|
2,932
|
|
|
$
|
3,244
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuer Purchases of Equity Securities
|
||||||||||||||||
Q1 Fiscal Periods
|
Total Number of Shares Purchased
|
Average Price Paid Per Share, including commission
|
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
|
|
Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (in millions)(1)
|
||||||||||
October 1, 2016 to October 31, 2016:
|
|
|
|
|
|
|
|
$
|
500
|
|
|
|||||
Employee Tax Withholdings
|
60
|
|
(2
|
)
|
|
$
|
115.95
|
|
|
—
|
|
|
|
|
||
November 1, 2016 to November 30, 2016:
|
|
|
|
|
|
|
|
|
500
|
|
|
|||||
Employee Tax Withholdings
|
20,893
|
|
(2
|
)
|
|
108.68
|
|
|
—
|
|
|
|
|
|||
December 1, 2016 to December 31, 2016:
|
|
|
|
|
|
|
|
500
|
|
|
||||||
Employee Tax Withholdings
|
360
|
|
(2
|
)
|
|
110.16
|
|
|
—
|
|
|
|
|
|||
Total
|
21,313
|
|
|
|
|
|
—
|
|
|
$
|
500
|
|
|
(a) Exhibits
|
|
10.1*
|
Amended and Restated Parent Undertaking, dated as of November 18, 2016, by Ashland LLC and Ashland Global Holdings Inc., as Guarantors, in favor of The Bank of Nova Scotia as Agent and the Secured Parties.
|
|
|
10.2*
|
Third Amendment dated as of November 18, 2016 to Sale Agreement dated as of August 31, 2012 among Ashland LLC, Ashland Specialty Ingredients G.P., each an Originator, and CVG Capital III LLC, as SPV.
|
|
|
10.3*
|
Thirteenth Amendment dated as of November 18, 2016 to the Transfer and Administration Agreement dated as of August 31, 2012 among Ashland LLC, as Master Servicer, CVG Capital III LLC, as SPV, the Originators, the Investors, Letter of Credit Issuers, Managing Agents and Administrators party thereto, and The Bank of Nova Scotia, as agent for the Investors.
|
|
|
10.4*
|
Amended and Restated Ashland Global Holdings Inc. Deferred Compensation Plan for Non-Employee Directors (2005) effective as of January 1, 2017.
|
|
|
10.5*
|
Guaranty Agreement dated as of November 16, 2016, (and effective as of October 19, 2016) between Ashland Global Holdings Inc., as Guarantor, and The Bank of Nova Scotia, as Administrative Agent.
|
|
|
10.6
|
Amended and Restated 2015 Ashland Global Holdings Inc. Incentive Plan (filed as Exhibit 10.21 to Ashland’s Form 10-K filed on November 21, 2016 (SEC File No. 333-211719), and incorporated herein by reference).
|
|
|
12*
|
Computation of Ratio of Earnings to Fixed Charges.
|
|
|
31.1*
|
Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2*
|
Certificate of J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32*
|
Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland, and J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101.INS**
|
XBRL Instance Document.
|
|
|
101.SCH**
|
XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL**
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF**
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB**
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE**
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
Ashland Global Holdings Inc.
|
|
(Registrant)
|
January 27, 2017
|
/s/ J. Kevin Willis
|
|
J. Kevin Willis
|
|
Senior Vice President and Chief Financial Officer
(on behalf of the Registrant and as principal
financial officer)
|
(a) Exhibits
|
|
10.1*
|
Amended and Restated Parent Undertaking, dated as of November 18, 2016, by Ashland LLC and Ashland Global Holdings Inc., as Guarantors, in favor of The Bank of Nova Scotia as Agent and the Secured Parties.
|
|
|
10.2*
|
Third Amendment dated as of November 18, 2016 to Sale Agreement dated as of August 31, 2012 among Ashland LLC, Ashland Specialty Ingredients G.P., each an Originator, and CVG Capital III LLC, as SPV.
|
|
|
10.3*
|
Thirteenth Amendment dated as of November 18, 2016 to the Transfer and Administration Agreement dated as of August 31, 2012 among Ashland LLC, as Master Servicer, CVG Capital III LLC, as SPV, the Originators, the Investors, Letter of Credit Issuers, Managing Agents and Administrators party thereto, and The Bank of Nova Scotia, as agent for the Investors.
|
|
|
10.4*
|
Amended and Restated Ashland Global Holdings Inc. Deferred Compensation Plan for Non-Employee Directors (2005) effective as of January 1, 2017.
|
|
|
10.5*
|
Guaranty Agreement dated as of November 16, 2016, (and effective as of October 19, 2016) between Ashland Global Holdings Inc., as Guarantor, and The Bank of Nova Scotia, as Administrative Agent.
|
|
|
10.6
|
Amended and Restated 2015 Ashland Global Holdings Inc. Incentive Plan (filed as Exhibit 10.21 to Ashland’s Form 10-K filed on November 21, 2016 (SEC File No. 333-211719), and incorporated herein by reference).
|
|
|
12*
|
Computation of Ratio of Earnings to Fixed Charges.
|
|
|
31.1*
|
Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
31.2*
|
Certificate of J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
32*
|
Certificate of William A. Wulfsohn, Chief Executive Officer of Ashland, and J. Kevin Willis, Chief Financial Officer of Ashland pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
|
|
101.INS**
|
XBRL Instance Document.
|
|
|
101.SCH**
|
XBRL Taxonomy Extension Schema Document.
|
|
|
101.CAL**
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
101.DEF**
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
101.LAB**
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
101.PRE**
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|